| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 35 | 2023 | 2715 | 4.070 |
Why?
|
| Diet, High-Fat | 19 | 2023 | 247 | 3.870 |
Why?
|
| Gastrointestinal Microbiome | 23 | 2022 | 538 | 3.720 |
Why?
|
| Placenta | 10 | 2023 | 637 | 3.360 |
Why?
|
| Pregnancy Complications | 15 | 2020 | 447 | 3.290 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 9 | 2023 | 157 | 3.030 |
Why?
|
| Pregnancy | 50 | 2023 | 5671 | 2.080 |
Why?
|
| Diet | 14 | 2023 | 1143 | 1.990 |
Why?
|
| Liver | 34 | 2022 | 1803 | 1.950 |
Why?
|
| Prenatal Exposure Delayed Effects | 9 | 2022 | 465 | 1.920 |
Why?
|
| DNA Methylation | 7 | 2022 | 501 | 1.870 |
Why?
|
| Soybean Proteins | 12 | 2020 | 22 | 1.840 |
Why?
|
| Bone Development | 5 | 2018 | 53 | 1.740 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 13 | 2023 | 277 | 1.660 |
Why?
|
| Rats | 60 | 2023 | 5339 | 1.580 |
Why?
|
| Ethanol | 14 | 2010 | 574 | 1.540 |
Why?
|
| Umbilical Cord | 3 | 2017 | 84 | 1.530 |
Why?
|
| Rats, Sprague-Dawley | 46 | 2020 | 2434 | 1.520 |
Why?
|
| Body Composition | 13 | 2023 | 644 | 1.480 |
Why?
|
| Lipid Metabolism | 12 | 2022 | 473 | 1.430 |
Why?
|
| Transcriptome | 11 | 2023 | 752 | 1.370 |
Why?
|
| Weight Gain | 11 | 2023 | 485 | 1.360 |
Why?
|
| Animals | 104 | 2023 | 33152 | 1.250 |
Why?
|
| Dietary Fats | 8 | 2023 | 323 | 1.190 |
Why?
|
| Gene Expression Profiling | 18 | 2021 | 1590 | 1.150 |
Why?
|
| Female | 95 | 2023 | 61261 | 1.140 |
Why?
|
| Fatty Liver | 8 | 2022 | 247 | 1.140 |
Why?
|
| Adiposity | 12 | 2023 | 508 | 1.120 |
Why?
|
| Gene Expression Regulation | 16 | 2020 | 2435 | 1.060 |
Why?
|
| Placentation | 2 | 2015 | 42 | 1.040 |
Why?
|
| Fetal Growth Retardation | 2 | 2023 | 468 | 1.030 |
Why?
|
| Diabetes Mellitus, Experimental | 7 | 2022 | 211 | 1.020 |
Why?
|
| Blueberry Plants | 4 | 2022 | 8 | 1.020 |
Why?
|
| Infant Formula | 8 | 2022 | 82 | 1.010 |
Why?
|
| Bone Resorption | 7 | 2021 | 80 | 1.010 |
Why?
|
| Osteoblasts | 7 | 2019 | 115 | 0.980 |
Why?
|
| Cell Differentiation | 11 | 2019 | 1746 | 0.930 |
Why?
|
| Mothers | 5 | 2023 | 675 | 0.890 |
Why?
|
| Chemical and Drug Induced Liver Injury | 10 | 2007 | 136 | 0.830 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2023 | 2159 | 0.830 |
Why?
|
| Animal Feed | 4 | 2019 | 55 | 0.820 |
Why?
|
| Feces | 7 | 2023 | 392 | 0.810 |
Why?
|
| Fetus | 3 | 2019 | 690 | 0.790 |
Why?
|
| Insulin Resistance | 8 | 2023 | 1167 | 0.770 |
Why?
|
| Pre-Eclampsia | 1 | 2023 | 183 | 0.770 |
Why?
|
| Premature Birth | 2 | 2023 | 284 | 0.740 |
Why?
|
| Musculoskeletal Development | 1 | 2019 | 5 | 0.730 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2019 | 5 | 0.730 |
Why?
|
| Body Mass Index | 10 | 2023 | 2074 | 0.720 |
Why?
|
| Early Growth Response Protein 1 | 3 | 2016 | 32 | 0.720 |
Why?
|
| Metabolome | 6 | 2022 | 288 | 0.710 |
Why?
|
| Transcription Factors | 5 | 2019 | 1567 | 0.700 |
Why?
|
| Estradiol | 9 | 2019 | 473 | 0.700 |
Why?
|
| Male | 72 | 2023 | 57474 | 0.690 |
Why?
|
| Adipogenesis | 4 | 2019 | 47 | 0.680 |
Why?
|
| Adipose Tissue, White | 2 | 2023 | 35 | 0.680 |
Why?
|
| Milk, Human | 4 | 2022 | 134 | 0.670 |
Why?
|
| Cecum | 5 | 2020 | 37 | 0.670 |
Why?
|
| Animals, Newborn | 11 | 2019 | 804 | 0.660 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2019 | 810 | 0.660 |
Why?
|
| Osteogenesis | 5 | 2021 | 213 | 0.650 |
Why?
|
| Fetal Development | 2 | 2023 | 250 | 0.650 |
Why?
|
| Epigenesis, Genetic | 5 | 2022 | 536 | 0.650 |
Why?
|
| Body Weight | 9 | 2021 | 923 | 0.650 |
Why?
|
| Overweight | 6 | 2020 | 492 | 0.650 |
Why?
|
| RNA, Messenger | 13 | 2016 | 2657 | 0.640 |
Why?
|
| Histone Acetyltransferases | 1 | 2018 | 53 | 0.630 |
Why?
|
| Fruit | 1 | 2019 | 129 | 0.630 |
Why?
|
| Oxidative Stress | 11 | 2019 | 1167 | 0.620 |
Why?
|
| Mice, Inbred C57BL | 14 | 2023 | 4887 | 0.610 |
Why?
|
| Caveolin 1 | 2 | 2016 | 23 | 0.610 |
Why?
|
| Weaning | 5 | 2014 | 57 | 0.610 |
Why?
|
| Adipose Tissue | 6 | 2023 | 595 | 0.600 |
Why?
|
| Maternal Exposure | 1 | 2018 | 140 | 0.600 |
Why?
|
| Disease Models, Animal | 14 | 2019 | 3676 | 0.590 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 13 | 2018 | 980 | 0.590 |
Why?
|
| Trophoblasts | 2 | 2015 | 168 | 0.570 |
Why?
|
| Infant, Newborn | 15 | 2023 | 5230 | 0.570 |
Why?
|
| Bacteria | 9 | 2023 | 751 | 0.570 |
Why?
|
| Bone Density | 6 | 2016 | 447 | 0.570 |
Why?
|
| Mice | 31 | 2023 | 15446 | 0.570 |
Why?
|
| Data Interpretation, Statistical | 1 | 2018 | 334 | 0.550 |
Why?
|
| Inflammation | 8 | 2022 | 2545 | 0.550 |
Why?
|
| Malnutrition | 4 | 2015 | 65 | 0.540 |
Why?
|
| Humans | 64 | 2023 | 118251 | 0.540 |
Why?
|
| Cellular Senescence | 4 | 2018 | 151 | 0.500 |
Why?
|
| Mitochondrial Dynamics | 1 | 2014 | 27 | 0.500 |
Why?
|
| Thyroid Hormones | 1 | 2014 | 55 | 0.490 |
Why?
|
| Pediatric Obesity | 4 | 2023 | 512 | 0.490 |
Why?
|
| Thioacetamide | 5 | 2006 | 6 | 0.470 |
Why?
|
| Leptin | 7 | 2021 | 228 | 0.470 |
Why?
|
| Wnt Proteins | 5 | 2013 | 140 | 0.470 |
Why?
|
| Software | 1 | 2018 | 566 | 0.460 |
Why?
|
| Abdominal Fat | 3 | 2023 | 48 | 0.460 |
Why?
|
| RNA, Ribosomal, 16S | 5 | 2022 | 507 | 0.460 |
Why?
|
| Exercise | 1 | 2023 | 1647 | 0.450 |
Why?
|
| Signal Transduction | 16 | 2023 | 4688 | 0.450 |
Why?
|
| Adiponectin | 3 | 2019 | 224 | 0.450 |
Why?
|
| Ecosystem | 1 | 2018 | 549 | 0.440 |
Why?
|
| Swine | 10 | 2022 | 719 | 0.430 |
Why?
|
| Dietary Carbohydrates | 4 | 2017 | 157 | 0.420 |
Why?
|
| Bile Acids and Salts | 5 | 2022 | 179 | 0.420 |
Why?
|
| Sequence Analysis, RNA | 3 | 2019 | 410 | 0.420 |
Why?
|
| Child Development | 2 | 2015 | 402 | 0.410 |
Why?
|
| Blastocyst | 1 | 2011 | 44 | 0.410 |
Why?
|
| Mammary Glands, Animal | 4 | 2013 | 122 | 0.400 |
Why?
|
| Central Nervous System Depressants | 4 | 2008 | 89 | 0.400 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 2 | 2014 | 66 | 0.400 |
Why?
|
| Genome | 1 | 2013 | 271 | 0.390 |
Why?
|
| Uterus | 2 | 2011 | 197 | 0.390 |
Why?
|
| Sirtuin 3 | 1 | 2011 | 60 | 0.380 |
Why?
|
| Blotting, Western | 8 | 2014 | 1186 | 0.380 |
Why?
|
| Infant | 12 | 2023 | 8254 | 0.370 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 394 | 0.370 |
Why?
|
| Birth Weight | 6 | 2023 | 463 | 0.370 |
Why?
|
| Carcinogens | 3 | 2008 | 107 | 0.360 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 2 | 2007 | 26 | 0.360 |
Why?
|
| Gene Expression | 7 | 2017 | 1482 | 0.360 |
Why?
|
| Cell Line | 6 | 2019 | 2693 | 0.350 |
Why?
|
| Mitochondria, Liver | 3 | 2019 | 70 | 0.350 |
Why?
|
| Steroid Hydroxylases | 2 | 2007 | 22 | 0.340 |
Why?
|
| Cytochrome P-450 CYP2E1 | 11 | 2008 | 38 | 0.330 |
Why?
|
| Insulin | 4 | 2023 | 2157 | 0.330 |
Why?
|
| Acetylcysteine | 6 | 2010 | 147 | 0.330 |
Why?
|
| Histones | 3 | 2022 | 546 | 0.330 |
Why?
|
| Follicular Fluid | 2 | 2019 | 8 | 0.330 |
Why?
|
| Colon | 3 | 2021 | 237 | 0.320 |
Why?
|
| Estrogens | 5 | 2022 | 329 | 0.320 |
Why?
|
| Pregnancy Outcome | 2 | 2023 | 349 | 0.320 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 469 | 0.320 |
Why?
|
| Lactation | 2 | 2010 | 156 | 0.320 |
Why?
|
| Milk | 4 | 2022 | 125 | 0.310 |
Why?
|
| Biomarkers | 6 | 2021 | 3567 | 0.310 |
Why?
|
| Sex Characteristics | 4 | 2023 | 667 | 0.310 |
Why?
|
| Cholecalciferol | 1 | 2007 | 49 | 0.310 |
Why?
|
| Ileum | 4 | 2021 | 100 | 0.300 |
Why?
|
| Milk Proteins | 2 | 2017 | 37 | 0.300 |
Why?
|
| Glucose | 4 | 2023 | 940 | 0.300 |
Why?
|
| Real-Time Polymerase Chain Reaction | 5 | 2018 | 333 | 0.300 |
Why?
|
| Energy Metabolism | 5 | 2019 | 762 | 0.300 |
Why?
|
| Triglycerides | 7 | 2022 | 515 | 0.300 |
Why?
|
| Physical Conditioning, Animal | 3 | 2019 | 204 | 0.300 |
Why?
|
| Isoflavones | 4 | 2022 | 24 | 0.290 |
Why?
|
| Antioxidants | 4 | 2019 | 564 | 0.290 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2012 | 764 | 0.280 |
Why?
|
| Adult | 16 | 2023 | 31324 | 0.280 |
Why?
|
| Intestine, Small | 3 | 2017 | 130 | 0.280 |
Why?
|
| NADPH Oxidases | 3 | 2019 | 122 | 0.280 |
Why?
|
| Down-Regulation | 5 | 2016 | 623 | 0.280 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2020 | 175 | 0.270 |
Why?
|
| Estrus | 1 | 2005 | 18 | 0.270 |
Why?
|
| Homeostasis | 3 | 2019 | 589 | 0.270 |
Why?
|
| Liver Neoplasms | 2 | 2020 | 526 | 0.260 |
Why?
|
| Pregnancy, Animal | 1 | 2005 | 57 | 0.260 |
Why?
|
| Epigenomics | 2 | 2016 | 106 | 0.260 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2020 | 36 | 0.260 |
Why?
|
| Ovariectomy | 3 | 2016 | 124 | 0.260 |
Why?
|
| Intra-Abdominal Fat | 2 | 2023 | 89 | 0.260 |
Why?
|
| beta Catenin | 3 | 2010 | 219 | 0.250 |
Why?
|
| Skull | 3 | 2016 | 127 | 0.250 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2017 | 179 | 0.250 |
Why?
|
| Kidney | 5 | 2007 | 1351 | 0.240 |
Why?
|
| Acetaminophen | 3 | 2003 | 244 | 0.240 |
Why?
|
| Overnutrition | 3 | 2017 | 39 | 0.240 |
Why?
|
| Alzheimer Disease | 2 | 2021 | 512 | 0.240 |
Why?
|
| Hepatocytes | 4 | 2019 | 204 | 0.240 |
Why?
|
| Tibia | 2 | 2020 | 177 | 0.230 |
Why?
|
| Fatty Acids | 7 | 2019 | 403 | 0.230 |
Why?
|
| Infant Health | 1 | 2023 | 21 | 0.230 |
Why?
|
| Breast Feeding | 2 | 2020 | 381 | 0.230 |
Why?
|
| Cohort Studies | 5 | 2022 | 5078 | 0.230 |
Why?
|
| Microbiota | 2 | 2023 | 655 | 0.230 |
Why?
|
| Calorimetry, Indirect | 2 | 2014 | 72 | 0.230 |
Why?
|
| Metabolomics | 4 | 2022 | 540 | 0.220 |
Why?
|
| Contraceptives, Oral | 1 | 2022 | 27 | 0.220 |
Why?
|
| Adipocytes | 4 | 2023 | 195 | 0.220 |
Why?
|
| Stromal Cells | 3 | 2012 | 100 | 0.220 |
Why?
|
| Membrane Proteins | 4 | 2021 | 1048 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 5 | 2014 | 1157 | 0.210 |
Why?
|
| Antigens, CD | 2 | 2016 | 457 | 0.210 |
Why?
|
| NADPH Oxidase 4 | 1 | 2022 | 10 | 0.210 |
Why?
|
| Oligosaccharides | 1 | 2022 | 47 | 0.210 |
Why?
|
| Muscle, Skeletal | 4 | 2023 | 1515 | 0.210 |
Why?
|
| Enteral Nutrition | 6 | 2012 | 172 | 0.210 |
Why?
|
| Forkhead Transcription Factors | 2 | 2013 | 181 | 0.210 |
Why?
|
| Child Health | 1 | 2023 | 136 | 0.210 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 194 | 0.200 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2003 | 116 | 0.200 |
Why?
|
| Butyrates | 1 | 2022 | 54 | 0.200 |
Why?
|
| Time Factors | 8 | 2016 | 6368 | 0.200 |
Why?
|
| Alcohol Dehydrogenase | 5 | 2008 | 22 | 0.200 |
Why?
|
| Alcoholism | 1 | 2008 | 714 | 0.200 |
Why?
|
| Hippurates | 1 | 2021 | 1 | 0.200 |
Why?
|
| Mentoring | 1 | 2023 | 101 | 0.200 |
Why?
|
| Women's Health | 1 | 2023 | 274 | 0.200 |
Why?
|
| Phenylpropionates | 1 | 2021 | 17 | 0.200 |
Why?
|
| Carcinogenesis | 2 | 2020 | 181 | 0.190 |
Why?
|
| Bone and Bones | 2 | 2015 | 288 | 0.190 |
Why?
|
| Metagenomics | 2 | 2018 | 134 | 0.190 |
Why?
|
| Longitudinal Studies | 7 | 2023 | 2491 | 0.190 |
Why?
|
| Proliferating Cell Nuclear Antigen | 7 | 2007 | 55 | 0.190 |
Why?
|
| Case-Control Studies | 5 | 2019 | 3156 | 0.190 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2019 | 285 | 0.190 |
Why?
|
| Temperature | 1 | 2023 | 621 | 0.190 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2020 | 9 | 0.190 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2020 | 6 | 0.190 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 161 | 0.190 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 2020 | 12 | 0.190 |
Why?
|
| Bottle Feeding | 1 | 2020 | 22 | 0.190 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 103 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2016 | 1159 | 0.180 |
Why?
|
| Dysbiosis | 2 | 2021 | 148 | 0.180 |
Why?
|
| Animals, Suckling | 2 | 2017 | 12 | 0.180 |
Why?
|
| Endocrine Disruptors | 1 | 2020 | 35 | 0.180 |
Why?
|
| Growth Plate | 1 | 2020 | 34 | 0.180 |
Why?
|
| Cholesterol | 3 | 2022 | 375 | 0.180 |
Why?
|
| Child | 10 | 2023 | 19033 | 0.180 |
Why?
|
| Trehalose | 1 | 2019 | 35 | 0.180 |
Why?
|
| Diabetic Angiopathies | 1 | 2022 | 261 | 0.180 |
Why?
|
| CpG Islands | 1 | 2020 | 119 | 0.180 |
Why?
|
| Intestinal Mucosa | 2 | 2021 | 529 | 0.180 |
Why?
|
| Dietary Proteins | 2 | 2012 | 131 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2009 | 1937 | 0.180 |
Why?
|
| Proto-Oncogenes | 1 | 2019 | 27 | 0.170 |
Why?
|
| Colchicine | 3 | 2003 | 27 | 0.170 |
Why?
|
| Fragaria | 1 | 2019 | 2 | 0.170 |
Why?
|
| Running | 2 | 2019 | 225 | 0.170 |
Why?
|
| Up-Regulation | 5 | 2022 | 862 | 0.170 |
Why?
|
| Clostridium Infections | 1 | 2019 | 57 | 0.170 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 192 | 0.170 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2019 | 44 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 2 | 2013 | 284 | 0.170 |
Why?
|
| Anthropometry | 2 | 2022 | 192 | 0.170 |
Why?
|
| Cell Division | 4 | 2005 | 775 | 0.170 |
Why?
|
| Parenteral Nutrition, Total | 3 | 2010 | 39 | 0.170 |
Why?
|
| C-Reactive Protein | 2 | 2020 | 364 | 0.170 |
Why?
|
| Child, Preschool | 9 | 2023 | 9448 | 0.170 |
Why?
|
| Immunohistochemistry | 6 | 2016 | 1681 | 0.170 |
Why?
|
| GTP-Binding Proteins | 1 | 2019 | 147 | 0.160 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2018 | 5 | 0.160 |
Why?
|
| Fertilization in Vitro | 1 | 2019 | 73 | 0.160 |
Why?
|
| Phytoestrogens | 1 | 2018 | 17 | 0.160 |
Why?
|
| Cells, Cultured | 4 | 2016 | 4044 | 0.160 |
Why?
|
| Programming Languages | 1 | 2018 | 23 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 219 | 0.160 |
Why?
|
| Sequence Analysis | 1 | 2018 | 36 | 0.160 |
Why?
|
| Microbiology | 1 | 2018 | 19 | 0.160 |
Why?
|
| Fatty Acid Synthases | 3 | 2020 | 29 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2014 | 288 | 0.160 |
Why?
|
| Plant Extracts | 1 | 2020 | 164 | 0.160 |
Why?
|
| Microbiological Techniques | 1 | 2018 | 31 | 0.160 |
Why?
|
| PPAR alpha | 3 | 2014 | 55 | 0.160 |
Why?
|
| Cysteine | 3 | 2003 | 184 | 0.160 |
Why?
|
| Postmenopause | 1 | 2020 | 305 | 0.160 |
Why?
|
| Cholesterol, Dietary | 1 | 2017 | 16 | 0.160 |
Why?
|
| Lipogenesis | 2 | 2019 | 66 | 0.160 |
Why?
|
| Cytokines | 4 | 2017 | 1880 | 0.160 |
Why?
|
| Physical Exertion | 1 | 2019 | 221 | 0.160 |
Why?
|
| Metagenome | 1 | 2018 | 120 | 0.160 |
Why?
|
| Tryptamines | 1 | 2017 | 4 | 0.160 |
Why?
|
| Embryonic Development | 1 | 2018 | 117 | 0.160 |
Why?
|
| Blood Glucose | 4 | 2021 | 1936 | 0.160 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 117 | 0.150 |
Why?
|
| Energy Intake | 4 | 2023 | 445 | 0.150 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2017 | 19 | 0.150 |
Why?
|
| Testis | 1 | 2018 | 144 | 0.150 |
Why?
|
| Prenatal Care | 2 | 2017 | 252 | 0.150 |
Why?
|
| Choline Deficiency | 1 | 2017 | 12 | 0.150 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 24 | 0.150 |
Why?
|
| Regression Analysis | 2 | 2017 | 984 | 0.150 |
Why?
|
| Prospective Studies | 3 | 2023 | 6443 | 0.150 |
Why?
|
| Phenotype | 4 | 2016 | 2937 | 0.150 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 392 | 0.150 |
Why?
|
| Time | 1 | 2017 | 77 | 0.150 |
Why?
|
| Diet, Western | 1 | 2017 | 69 | 0.150 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 301 | 0.150 |
Why?
|
| Reactive Oxygen Species | 4 | 2022 | 571 | 0.150 |
Why?
|
| Mitochondrial Proteins | 2 | 2019 | 224 | 0.150 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 268 | 0.150 |
Why?
|
| Activating Transcription Factor 3 | 2 | 2013 | 6 | 0.140 |
Why?
|
| Liver Diseases | 4 | 2003 | 282 | 0.140 |
Why?
|
| Soy Milk | 2 | 2017 | 2 | 0.140 |
Why?
|
| Methionine | 1 | 2017 | 145 | 0.140 |
Why?
|
| Tryptophan | 1 | 2017 | 138 | 0.140 |
Why?
|
| Soy Foods | 1 | 2016 | 4 | 0.140 |
Why?
|
| Choline | 1 | 2017 | 109 | 0.140 |
Why?
|
| Oocytes | 1 | 2017 | 190 | 0.140 |
Why?
|
| Pregnancy Trimester, First | 1 | 2016 | 126 | 0.140 |
Why?
|
| Rest | 1 | 2016 | 104 | 0.140 |
Why?
|
| Thinness | 1 | 2016 | 91 | 0.140 |
Why?
|
| Interleukin-8 | 2 | 2016 | 240 | 0.140 |
Why?
|
| Mitochondria | 3 | 2022 | 785 | 0.140 |
Why?
|
| Cell Fusion | 1 | 2015 | 51 | 0.140 |
Why?
|
| Fructose | 1 | 2017 | 198 | 0.140 |
Why?
|
| Aldehyde Dehydrogenase | 2 | 2007 | 134 | 0.130 |
Why?
|
| Enzyme Induction | 4 | 2010 | 92 | 0.130 |
Why?
|
| Mice, Knockout | 5 | 2021 | 2664 | 0.130 |
Why?
|
| Carbon Tetrachloride | 3 | 2003 | 9 | 0.130 |
Why?
|
| Registries | 1 | 2023 | 1806 | 0.130 |
Why?
|
| Thiazolidinediones | 1 | 2016 | 146 | 0.130 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 967 | 0.130 |
Why?
|
| Prediabetic State | 1 | 2018 | 228 | 0.130 |
Why?
|
| Hyperphagia | 1 | 2015 | 31 | 0.130 |
Why?
|
| Serotonin | 1 | 2017 | 308 | 0.130 |
Why?
|
| Immunoblotting | 2 | 2016 | 304 | 0.130 |
Why?
|
| Prenatal Diagnosis | 1 | 2016 | 167 | 0.130 |
Why?
|
| Child of Impaired Parents | 1 | 2015 | 41 | 0.130 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2016 | 106 | 0.130 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2014 | 13 | 0.130 |
Why?
|
| Biodiversity | 1 | 2018 | 376 | 0.130 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 116 | 0.130 |
Why?
|
| Phylogeny | 1 | 2018 | 817 | 0.130 |
Why?
|
| Cadherins | 1 | 2016 | 186 | 0.130 |
Why?
|
| Food, Formulated | 2 | 2017 | 19 | 0.130 |
Why?
|
| Behavior Therapy | 1 | 2017 | 236 | 0.130 |
Why?
|
| Ovary | 1 | 2016 | 205 | 0.130 |
Why?
|
| Metalloproteases | 1 | 2014 | 38 | 0.120 |
Why?
|
| Cell Proliferation | 4 | 2016 | 2262 | 0.120 |
Why?
|
| Metformin | 1 | 2018 | 293 | 0.120 |
Why?
|
| Exercise Tolerance | 1 | 2016 | 234 | 0.120 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 69 | 0.120 |
Why?
|
| Interleukin-6 | 3 | 2016 | 685 | 0.120 |
Why?
|
| Culture Media | 1 | 2014 | 161 | 0.120 |
Why?
|
| Diabetes, Gestational | 1 | 2018 | 284 | 0.120 |
Why?
|
| Microarray Analysis | 1 | 2014 | 121 | 0.120 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2013 | 12 | 0.120 |
Why?
|
| Models, Biological | 3 | 2014 | 1701 | 0.120 |
Why?
|
| Escherichia coli Proteins | 1 | 2015 | 170 | 0.120 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 30 | 0.120 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2005 | 111 | 0.120 |
Why?
|
| Transcription Initiation Site | 1 | 2014 | 42 | 0.120 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 26 | 0.120 |
Why?
|
| GPI-Linked Proteins | 1 | 2013 | 56 | 0.120 |
Why?
|
| Biological Clocks | 1 | 2014 | 40 | 0.120 |
Why?
|
| Semaphorins | 1 | 2013 | 22 | 0.120 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 94 | 0.120 |
Why?
|
| Kidney Tubular Necrosis, Acute | 2 | 2003 | 25 | 0.120 |
Why?
|
| Growth | 2 | 2010 | 58 | 0.120 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2014 | 155 | 0.120 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 275 | 0.120 |
Why?
|
| Palmitates | 1 | 2013 | 18 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2014 | 193 | 0.110 |
Why?
|
| Serum Response Factor | 1 | 2013 | 31 | 0.110 |
Why?
|
| White Matter | 1 | 2015 | 115 | 0.110 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 177 | 0.110 |
Why?
|
| Alanine Transaminase | 5 | 2007 | 151 | 0.110 |
Why?
|
| Tissue Distribution | 1 | 2013 | 332 | 0.110 |
Why?
|
| DNA Primers | 1 | 2014 | 532 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 189 | 0.110 |
Why?
|
| Gene Regulatory Networks | 2 | 2017 | 238 | 0.110 |
Why?
|
| Disease Management | 1 | 2017 | 566 | 0.110 |
Why?
|
| Microsomes, Liver | 4 | 2006 | 59 | 0.110 |
Why?
|
| Risk Factors | 6 | 2021 | 8958 | 0.110 |
Why?
|
| SOX Transcription Factors | 1 | 2012 | 1 | 0.110 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2012 | 22 | 0.110 |
Why?
|
| GATA Transcription Factors | 1 | 2012 | 8 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 244 | 0.110 |
Why?
|
| Lysine | 1 | 2014 | 247 | 0.100 |
Why?
|
| Organ Size | 5 | 2012 | 460 | 0.100 |
Why?
|
| Endometrium | 1 | 2012 | 61 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 55 | 0.100 |
Why?
|
| Parents | 1 | 2019 | 1208 | 0.100 |
Why?
|
| Endometriosis | 1 | 2012 | 42 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 287 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 817 | 0.100 |
Why?
|
| Proteins | 1 | 2017 | 935 | 0.100 |
Why?
|
| Hydroxybenzoates | 1 | 2010 | 11 | 0.100 |
Why?
|
| NF-kappa B | 2 | 2006 | 664 | 0.100 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 219 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2014 | 1288 | 0.100 |
Why?
|
| Gestational Age | 3 | 2019 | 765 | 0.100 |
Why?
|
| Genistein | 3 | 2022 | 20 | 0.100 |
Why?
|
| Plethysmography | 2 | 2022 | 124 | 0.100 |
Why?
|
| Hypoglycemic Agents | 1 | 2018 | 1031 | 0.090 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2010 | 131 | 0.090 |
Why?
|
| Receptors, Steroid | 1 | 2010 | 54 | 0.090 |
Why?
|
| Resistin | 1 | 2010 | 13 | 0.090 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2010 | 60 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1433 | 0.090 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2010 | 38 | 0.090 |
Why?
|
| Adenylate Kinase | 1 | 2010 | 29 | 0.090 |
Why?
|
| Eating | 3 | 2022 | 366 | 0.090 |
Why?
|
| Models, Animal | 1 | 2012 | 349 | 0.090 |
Why?
|
| Hyperinsulinism | 1 | 2011 | 107 | 0.090 |
Why?
|
| Epithelium | 1 | 2011 | 303 | 0.090 |
Why?
|
| Metabolic Clearance Rate | 2 | 2007 | 111 | 0.090 |
Why?
|
| Endocrine System | 1 | 2009 | 22 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 563 | 0.090 |
Why?
|
| Carbohydrate Metabolism | 1 | 2009 | 50 | 0.090 |
Why?
|
| Iron | 1 | 2011 | 247 | 0.090 |
Why?
|
| Base Sequence | 1 | 2013 | 2148 | 0.090 |
Why?
|
| RNA Interference | 1 | 2011 | 459 | 0.090 |
Why?
|
| Young Adult | 3 | 2020 | 10731 | 0.090 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2009 | 31 | 0.090 |
Why?
|
| Receptors, Progesterone | 1 | 2012 | 325 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 274 | 0.090 |
Why?
|
| PPAR gamma | 1 | 2010 | 187 | 0.090 |
Why?
|
| DNA | 4 | 2003 | 1385 | 0.090 |
Why?
|
| Agouti Signaling Protein | 1 | 2008 | 3 | 0.080 |
Why?
|
| Genotype | 1 | 2014 | 1870 | 0.080 |
Why?
|
| Hair Color | 1 | 2008 | 11 | 0.080 |
Why?
|
| Fibroblast Growth Factors | 1 | 2010 | 174 | 0.080 |
Why?
|
| Dexamethasone | 1 | 2010 | 319 | 0.080 |
Why?
|
| Enzymes | 3 | 2003 | 66 | 0.080 |
Why?
|
| Osteoporosis | 1 | 2011 | 226 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 341 | 0.080 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2008 | 9 | 0.080 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2007 | 15 | 0.080 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2009 | 156 | 0.080 |
Why?
|
| Corn Oil | 1 | 2007 | 3 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 4574 | 0.080 |
Why?
|
| Free Radical Scavengers | 1 | 2008 | 88 | 0.080 |
Why?
|
| Hepatitis | 1 | 2008 | 46 | 0.080 |
Why?
|
| Cytochrome P-450 CYP2E1 Inhibitors | 3 | 2003 | 5 | 0.080 |
Why?
|
| Calcitriol | 1 | 2007 | 55 | 0.080 |
Why?
|
| Toxins, Biological | 1 | 2007 | 16 | 0.080 |
Why?
|
| Amino Acids | 2 | 2023 | 462 | 0.080 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2008 | 60 | 0.080 |
Why?
|
| Liver Regeneration | 2 | 2007 | 34 | 0.080 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 3 | 2012 | 52 | 0.080 |
Why?
|
| Xenobiotics | 1 | 2007 | 25 | 0.080 |
Why?
|
| Phenobarbital | 1 | 2006 | 18 | 0.070 |
Why?
|
| Random Allocation | 3 | 2018 | 344 | 0.070 |
Why?
|
| Aspartate Aminotransferases | 2 | 2006 | 94 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2007 | 173 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3358 | 0.070 |
Why?
|
| Carnitine | 2 | 2017 | 65 | 0.070 |
Why?
|
| Rats, Inbred OLETF | 2 | 2017 | 2 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2023 | 12929 | 0.070 |
Why?
|
| Genetic Markers | 2 | 2021 | 347 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 2022 | 404 | 0.070 |
Why?
|
| Caloric Restriction | 1 | 2006 | 91 | 0.070 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 939 | 0.070 |
Why?
|
| Beer | 1 | 2005 | 6 | 0.070 |
Why?
|
| Wnt Signaling Pathway | 2 | 2021 | 150 | 0.070 |
Why?
|
| Adolescent | 5 | 2023 | 18364 | 0.070 |
Why?
|
| Feeding Behavior | 2 | 2023 | 595 | 0.070 |
Why?
|
| Enzyme Inhibitors | 3 | 2010 | 817 | 0.070 |
Why?
|
| Progesterone | 2 | 2022 | 242 | 0.060 |
Why?
|
| Allyl Compounds | 2 | 2001 | 17 | 0.060 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 2003 | 3 | 0.060 |
Why?
|
| Osteocalcin | 2 | 2015 | 35 | 0.060 |
Why?
|
| Glutathione | 4 | 2008 | 324 | 0.060 |
Why?
|
| Sulfides | 2 | 2001 | 96 | 0.060 |
Why?
|
| Bromobenzenes | 1 | 2003 | 1 | 0.060 |
Why?
|
| Calpain | 1 | 2003 | 54 | 0.060 |
Why?
|
| Cytoprotection | 1 | 2003 | 55 | 0.060 |
Why?
|
| Liver Glycogen | 1 | 2003 | 23 | 0.060 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2023 | 1 | 0.060 |
Why?
|
| Sucrose | 1 | 2023 | 104 | 0.060 |
Why?
|
| Chondrocytes | 1 | 2005 | 206 | 0.060 |
Why?
|
| Sex Factors | 3 | 2013 | 1765 | 0.060 |
Why?
|
| Thermogenesis | 1 | 2023 | 43 | 0.060 |
Why?
|
| Sugars | 1 | 2023 | 32 | 0.060 |
Why?
|
| Rats, Wistar | 1 | 2023 | 396 | 0.050 |
Why?
|
| Lauric Acids | 1 | 2022 | 4 | 0.050 |
Why?
|
| Disease Susceptibility | 2 | 2016 | 330 | 0.050 |
Why?
|
| Adipose Tissue, Brown | 1 | 2023 | 71 | 0.050 |
Why?
|
| Prognosis | 2 | 2021 | 3424 | 0.050 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2022 | 15 | 0.050 |
Why?
|
| Clostridiales | 1 | 2021 | 1 | 0.050 |
Why?
|
| Veillonellaceae | 1 | 2021 | 1 | 0.050 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2021 | 8 | 0.050 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2021 | 5 | 0.050 |
Why?
|
| Vitamins | 1 | 2023 | 157 | 0.050 |
Why?
|
| Starch | 1 | 2022 | 24 | 0.050 |
Why?
|
| Caseins | 2 | 2012 | 22 | 0.050 |
Why?
|
| United States | 4 | 2021 | 12488 | 0.050 |
Why?
|
| Acetylation | 1 | 2022 | 216 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2021 | 23 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2017 | 479 | 0.050 |
Why?
|
| Mentors | 1 | 2023 | 165 | 0.050 |
Why?
|
| Diet Surveys | 1 | 2021 | 84 | 0.050 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2022 | 162 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2021 | 123 | 0.050 |
Why?
|
| Lipase | 1 | 2021 | 67 | 0.050 |
Why?
|
| Necrosis | 3 | 2007 | 230 | 0.050 |
Why?
|
| Rats, Transgenic | 1 | 2020 | 14 | 0.050 |
Why?
|
| Bixaceae | 1 | 2020 | 1 | 0.050 |
Why?
|
| Reproduction | 1 | 2022 | 189 | 0.050 |
Why?
|
| Tocotrienols | 1 | 2020 | 4 | 0.050 |
Why?
|
| 3T3-L1 Cells | 2 | 2011 | 35 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 178 | 0.050 |
Why?
|
| Body Weights and Measures | 1 | 2020 | 34 | 0.050 |
Why?
|
| Disaccharidases | 1 | 2019 | 2 | 0.050 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 316 | 0.050 |
Why?
|
| Carotenoids | 1 | 2020 | 35 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 2262 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 964 | 0.050 |
Why?
|
| Oxylipins | 1 | 2020 | 28 | 0.050 |
Why?
|
| Caco-2 Cells | 1 | 2019 | 66 | 0.040 |
Why?
|
| Endocannabinoids | 1 | 2020 | 37 | 0.040 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2020 | 47 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2003 | 603 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2021 | 199 | 0.040 |
Why?
|
| CD36 Antigens | 2 | 2011 | 40 | 0.040 |
Why?
|
| Receptor Cross-Talk | 1 | 2019 | 22 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 154 | 0.040 |
Why?
|
| Child Behavior | 1 | 2021 | 213 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2019 | 26 | 0.040 |
Why?
|
| Protein Transport | 2 | 2010 | 407 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2010 | 134 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1957 | 0.040 |
Why?
|
| Diet, Fat-Restricted | 1 | 2019 | 76 | 0.040 |
Why?
|
| Docosahexaenoic Acids | 1 | 2019 | 70 | 0.040 |
Why?
|
| Osteoclasts | 2 | 2010 | 36 | 0.040 |
Why?
|
| Linear Models | 1 | 2021 | 817 | 0.040 |
Why?
|
| Bacteroides | 1 | 2018 | 17 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2003 | 439 | 0.040 |
Why?
|
| Firmicutes | 1 | 2018 | 20 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2019 | 279 | 0.040 |
Why?
|
| Fasting | 1 | 2019 | 256 | 0.040 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 935 | 0.040 |
Why?
|
| Disease Progression | 2 | 2021 | 2477 | 0.040 |
Why?
|
| Serum | 1 | 2018 | 62 | 0.040 |
Why?
|
| Cytochrome P-450 CYP4A | 2 | 2007 | 6 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2020 | 443 | 0.040 |
Why?
|
| Clostridium | 1 | 2017 | 15 | 0.040 |
Why?
|
| Motor Activity | 1 | 2022 | 664 | 0.040 |
Why?
|
| Aminoisobutyric Acids | 1 | 2017 | 8 | 0.040 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2017 | 4 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 3169 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2017 | 725 | 0.040 |
Why?
|
| Oocyte Retrieval | 1 | 2017 | 12 | 0.040 |
Why?
|
| Acinetobacter | 1 | 2017 | 14 | 0.040 |
Why?
|
| Chemokine CXCL2 | 1 | 2017 | 44 | 0.040 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2017 | 29 | 0.040 |
Why?
|
| Streptococcus | 1 | 2017 | 24 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 625 | 0.040 |
Why?
|
| Blood Chemical Analysis | 1 | 2017 | 94 | 0.040 |
Why?
|
| Arkansas | 1 | 2017 | 15 | 0.040 |
Why?
|
| RANK Ligand | 2 | 2007 | 28 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 698 | 0.040 |
Why?
|
| Ovulation Induction | 1 | 2017 | 50 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 227 | 0.040 |
Why?
|
| Population Dynamics | 1 | 2018 | 136 | 0.040 |
Why?
|
| Duodenum | 1 | 2017 | 67 | 0.040 |
Why?
|
| Aerobiosis | 1 | 2016 | 21 | 0.040 |
Why?
|
| Parity | 1 | 2017 | 100 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 287 | 0.040 |
Why?
|
| Citric Acid Cycle | 1 | 2016 | 45 | 0.040 |
Why?
|
| Versicans | 1 | 2016 | 6 | 0.040 |
Why?
|
| Chemokine CXCL11 | 1 | 2016 | 4 | 0.040 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2016 | 6 | 0.040 |
Why?
|
| Androgens | 1 | 2018 | 167 | 0.040 |
Why?
|
| Aurora Kinase B | 1 | 2016 | 9 | 0.040 |
Why?
|
| Sulfoxides | 2 | 2006 | 4 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2022 | 717 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 52 | 0.040 |
Why?
|
| Protein Binding | 2 | 2017 | 1969 | 0.040 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2016 | 7 | 0.040 |
Why?
|
| Peyer's Patches | 1 | 2016 | 8 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 585 | 0.040 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2016 | 46 | 0.040 |
Why?
|
| Interleukin-9 | 1 | 2016 | 11 | 0.040 |
Why?
|
| Receptors, CCR2 | 1 | 2016 | 30 | 0.040 |
Why?
|
| Granulosa Cells | 1 | 2016 | 30 | 0.040 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2016 | 38 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2016 | 48 | 0.040 |
Why?
|
| Interleukin-27 | 1 | 2016 | 12 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2016 | 38 | 0.030 |
Why?
|
| Lipids | 1 | 2020 | 591 | 0.030 |
Why?
|
| Adolescent Behavior | 1 | 2021 | 480 | 0.030 |
Why?
|
| Fas Ligand Protein | 1 | 2016 | 60 | 0.030 |
Why?
|
| Jejunum | 1 | 2016 | 30 | 0.030 |
Why?
|
| Obstetrics | 1 | 2018 | 162 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 2016 | 394 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2016 | 124 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 194 | 0.030 |
Why?
|
| Interleukin-15 | 1 | 2016 | 77 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2020 | 1683 | 0.030 |
Why?
|
| Uric Acid | 1 | 2019 | 349 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 186 | 0.030 |
Why?
|
| Health Behavior | 1 | 2021 | 714 | 0.030 |
Why?
|
| Procollagen | 1 | 2015 | 21 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2022 | 890 | 0.030 |
Why?
|
| Anisotropy | 1 | 2015 | 65 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2007 | 154 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2019 | 468 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2015 | 73 | 0.030 |
Why?
|
| Interferon-alpha | 1 | 2016 | 191 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 114 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 1237 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2016 | 211 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2015 | 226 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2018 | 701 | 0.030 |
Why?
|
| Lipid Peroxidation | 2 | 2005 | 156 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2016 | 303 | 0.030 |
Why?
|
| Biotransformation | 2 | 2006 | 52 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 398 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2016 | 304 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 418 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 762 | 0.030 |
Why?
|
| Cytosol | 2 | 2005 | 214 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 1221 | 0.030 |
Why?
|
| Estrogen Receptor beta | 1 | 2013 | 37 | 0.030 |
Why?
|
| S Phase | 2 | 2003 | 74 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 548 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 523 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 497 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 454 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2012 | 56 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 124 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 75 | 0.030 |
Why?
|
| Calcitonin | 1 | 2012 | 29 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 683 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2017 | 912 | 0.030 |
Why?
|
| Sexual Maturation | 1 | 2012 | 49 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2003 | 1967 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2012 | 90 | 0.030 |
Why?
|
| Hepcidins | 1 | 2011 | 24 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2011 | 48 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 1857 | 0.030 |
Why?
|
| Cell Shape | 1 | 2011 | 57 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2012 | 158 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2012 | 137 | 0.030 |
Why?
|
| Kinetics | 2 | 2006 | 1623 | 0.030 |
Why?
|
| Myofibrils | 1 | 2011 | 50 | 0.020 |
Why?
|
| Aged | 2 | 2021 | 19594 | 0.020 |
Why?
|
| Myosins | 1 | 2011 | 129 | 0.020 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2011 | 78 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 4521 | 0.020 |
Why?
|
| Onium Compounds | 1 | 2010 | 13 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2015 | 700 | 0.020 |
Why?
|
| Midazolam | 1 | 2010 | 49 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 386 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 82 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2010 | 21 | 0.020 |
Why?
|
| Breast | 1 | 2011 | 140 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2010 | 64 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 82 | 0.020 |
Why?
|
| Calcium | 1 | 2016 | 1151 | 0.020 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2009 | 9 | 0.020 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2009 | 56 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2009 | 108 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2008 | 107 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 316 | 0.020 |
Why?
|
| Apoptosis | 2 | 2008 | 2461 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 849 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2007 | 62 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2010 | 577 | 0.020 |
Why?
|
| Cytochrome P-450 CYP2B1 | 1 | 2006 | 2 | 0.020 |
Why?
|
| Half-Life | 1 | 2006 | 147 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2006 | 43 | 0.020 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2007 | 87 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 6541 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2006 | 265 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2010 | 1622 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1322 | 0.020 |
Why?
|
| Lymphotoxin-alpha | 1 | 2005 | 10 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2007 | 351 | 0.020 |
Why?
|
| Species Specificity | 1 | 2007 | 559 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2007 | 186 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 160 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2005 | 30 | 0.020 |
Why?
|
| Cytochromes b5 | 1 | 2005 | 3 | 0.020 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2005 | 11 | 0.020 |
Why?
|
| Apoproteins | 1 | 2005 | 13 | 0.020 |
Why?
|
| Kupffer Cells | 1 | 2005 | 47 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 317 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 209 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 4684 | 0.020 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2005 | 88 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2006 | 252 | 0.020 |
Why?
|
| Oxidants | 1 | 2005 | 119 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2005 | 293 | 0.020 |
Why?
|
| Aldehydes | 1 | 2005 | 154 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2005 | 297 | 0.020 |
Why?
|
| Immune System | 1 | 2005 | 181 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2003 | 53 | 0.010 |
Why?
|
| Health Status | 1 | 2009 | 723 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2003 | 50 | 0.010 |
Why?
|
| Mercuric Chloride | 1 | 2003 | 3 | 0.010 |
Why?
|
| Dipeptides | 1 | 2003 | 51 | 0.010 |
Why?
|
| Blood Proteins | 1 | 2005 | 240 | 0.010 |
Why?
|
| Age Factors | 1 | 2011 | 2990 | 0.010 |
Why?
|
| Thymidine | 1 | 2003 | 62 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 2003 | 59 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2003 | 195 | 0.010 |
Why?
|
| Survival | 1 | 2003 | 39 | 0.010 |
Why?
|
| Brain | 1 | 2015 | 2481 | 0.010 |
Why?
|
| Urodynamics | 1 | 2003 | 31 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2009 | 951 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2005 | 753 | 0.010 |
Why?
|
| Survival Rate | 1 | 2007 | 1716 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2003 | 131 | 0.010 |
Why?
|
| Cattle | 1 | 2005 | 974 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 1062 | 0.010 |
Why?
|
| DNA Replication | 1 | 2003 | 210 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2005 | 857 | 0.010 |
Why?
|
| Regeneration | 1 | 2003 | 166 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2008 | 1334 | 0.010 |
Why?
|
| Oxygenases | 1 | 2000 | 10 | 0.010 |
Why?
|
| Macrophages | 1 | 2007 | 1311 | 0.010 |
Why?
|
| Isoniazid | 1 | 2000 | 53 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 27510 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 1787 | 0.010 |
Why?
|
| Indoles | 1 | 2000 | 311 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 2433 | 0.010 |
Why?
|